74.57
1.17%
-0.88
Vaxcyte Inc Azioni (PCVX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
74.01%
196.68
|
113.03 | 87.15 | 71.19 | 86.57 |
Interest Income/Expense |
-
|
- | - | - | - |
Depreciation and Amortization |
12.50%
0.90
|
0.80 | 0.80 | 0.70 | 0.70 |
Operating Income/Loss |
74.01%
-196.68
|
-113.03 | -87.15 | -71.19 | -86.57 |
Income/Loss From Continuing Operations Before Tax |
95.11%
-180.80
|
-92.66 | -68.34 | -60.46 | -78.05 |
Income/Loss From Continuing Operations After Tax |
95.11%
-180.80
|
-92.66 | -68.34 | -60.46 | -78.05 |
Net Income/Loss
|
95.11%
-180.80
|
-92.66 | -68.34 | -60.46 | -78.05 |
Preferred Stock Dividends And Other Adjustments |
339.00%
442.93
|
-185.33 | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
98.24%
1.7899
|
101.67 | 98.06 | 86.21 | 4.7114 |
Diluted Average Shares |
98.24%
1.7899
|
101.67 | 98.06 | 86.21 | 4.7114 |
Basic Earnings Per Share |
100.00%
-1.82
|
-0.91 | -0.70 | -0.70 | -1.02 |
Diluted Earnings Per Share |
100.00%
-1.82
|
-0.91 | -0.70 | -0.70 | -1.02 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
339.00%
442.93
|
-185.33 | - | - | - |
Capitalizzazione:
|
Volume (24 ore):